FDA.reportPublic FDA data

Application 040484

Type
ANDA
Sponsor
AKORN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ORPHENADRINE CITRATEORPHENADRINE CITRATEINJECTABLE;INJECTION30MG/MLNoYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
17478-538Orphenadrine CitrateOrphenadrine CitrateAkorn, Inc.ANDACurrent
17478-538Orphenadrine CitrateOrphenadrine CitrateAkornANDACurrent
17478-538Orphenadrine CitrateOrphenadrine CitrateAkorn, Inc.ANDACurrent
17478-538Orphenadrine CitrateOrphenadrine CitrateAkorn, Inc.ANDACurrent
17478-538Orphenadrine CitrateOrphenadrine CitrateAkornANDACurrent
17478-538Orphenadrine CitrateOrphenadrine CitrateAkorn, Inc.ANDACurrent
50090-2438Orphenadrine CitrateOrphenadrine CitrateA-S Medication SolutionsANDACurrent
50090-2438Orphenadrine CitrateOrphenadrine CitrateA-S Medication SolutionsANDACurrent